Vaccine inequity continues to be one of the greatest challenges in the pandemic - with only 10% of those in low- and middle-income countries fully vaccinated. One of the biggest hold-ups is a lack of vaccine manufacturing capacity in poorer nations. But now, researchers at the WHO technology-transfer hub have completed the first step in a project aimed at building vaccine manufacturing capacity in the Global South, by successfully replicating Moderna's COVID vaccine without assistance from the US-based biotech company. In this episode of&nbsp;Coronapod, we ask how they did it? What happens next? What the legal ramifications might be and what this could mean for the future of vaccine manufacture in low- and middle-income countries? Both during the pandemic and beyond.News:&nbsp;<a href="https://www.nature.com/articles/d41586-022-00293-2" rel="noopener noreferrer" target="_blank">South African scientists copy Moderna's COVID vaccine</a>News:&nbsp;<a href="http://" rel="noopener noreferrer" target="_blank">The fight to manufacture COVID vaccines in lower-income countries</a>Editorial:&nbsp;<a href="https://www.nature.com/articles/d41586-022-00335-9" rel="noopener noreferrer" target="_blank">Africa is bringing vaccine manufacturing home</a>﻿<a href="https://go.nature.com/get-the-nature-briefing?utm_source=coronapod&utm_medium=podcast&utm_campaign=shownotes" rel="noopener noreferrer" target="_blank">﻿Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.</a> &#10;&nbsp;<hr>See <a style='color: grey; ' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for privacy and opt-out information.

Podurama

Home

Trending

Personal

Your Podcasts

New Episodes

My Files

Favourite Episodes

Tags (Folders)

Recently Played

Bookmarks

Followed Playlists

Coronapod: How African scientists are copying Moderna's COVID vaccine

Nature Podcast